It was demonstrated that high levels of M2-type macrophages (marked as CD204 or CD206) (Ding et al., 2014), neutrophils (Liang et al., 2014), Tregs (Iwata et al., 2019) were defined as the adverse prognostic factors in glioma. The gene discussed is MRC1; the disease is glioma.